Diabetic Retinopathy Epidemiology Forecast

DelveInsight’s ‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018–2030

Diabetic Retinopathy Disease Understanding

Diabetic retinopathy (DR) is a common and specific microvascular complication of diabetes and remains the leading cause of preventable blindness in working-aged people. It is identified in a third of people with diabetes and is associated with increased risk of life-threatening systemic vascular complications, including stroke, coronary heart disease, and heart failure. In the US, an estimated 40% (8% for vision-threatening retinopathy) of people with type 2 diabetes and 86% (42%) with type 1 diabetes have diabetic retinopathy.


Epidemiological, clinical, and laboratory studies have increased the understanding of the pathophysiological changes of diabetic retinopathy, culminating recently in new treatment options for diabetic macular edema. Furthermore, screening programs have enabled early diagnosis and prompt treatment of sight-threatening retinopathy. Despite these advances in the field, the prevalence of diabetic retinopathy remains high at 40%. Globally, there are approximately 93 million people with diabetic retinopathy, 17 million with proliferative retinopathy, 21 million with diabetic macular edema, and 28 million with sight-threatening retinopathy, making diabetic retinopathy a significant global public health and economic problem.

Diabetic Retinopathy Epidemiology

The Diabetic Retinopathy epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.


Key Findings

The total prevalent cases of Diabetic Retinopathy patients are increasing in 7MM during the study period, i.e. 2018–2030.


The disease epidemiology covered in the report provides historical as well as forecasted Diabetic Retinopathy symptoms epidemiology segmented as the Total Diagnosed Prevalent cases of Diabetic Retinopathy, Gender-specific cases of Diabetic Retinopathy, Age-specific cases of Diabetic Retinopathy, and Severity-specific cases of Diabetic Retinopathy. The report includes the prevalent scenario of Diabetic Retinopathy symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Diabetic Retinopathy Epidemiology

The epidemiology segment also provides the Diabetic Retinopathy epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

  • The total diagnosed cases of Diabetic Retinopathy associated in 7MM countries were 8,033,083 in 2020.
  • As per the estimates, the United States has the largest diagnosed population of Diabetic Retinopathy.
  • Among the European countries, in 2020, Germany had the highest population of diabetic retinopathy with 2,167,200 cases, followed by Italy, which had 1,485,668 cases. On the other hand, the UK had the lowest number of cases 855,039 in 2020.
  • In 2020, diagnosed prevalent cases of diabetic retinopathy in the US varied according to gender; 2,181,806 and 2,190,498 cases for females and males, respectively, which are likely to increase in the forecast period.
  • Age plays an important role in diabetic retinopathy as it is most common in the older population. In 2020, there were 1,632,516 cases in the age group 50–64 and 354,420 cases in the age group 30–39, which are likely to rise by 2030 in the US.

Scope of the Report

  • The Diabetic Retinopathy report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
  • The Diabetic Retinopathy Epidemiology Report and Model provide an overview of the risk factors and 7MM trends of Diabetic Retinopathy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides insight into the historical and forecasted patient pool of Diabetic Retinopathy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Diabetic Retinopathy.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Diagnosed Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Gender-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Age-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Severity-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.

Report Highlights

  • 10-Year Forecast of Diabetic Retinopathy epidemiology
  • 7MM Coverage
  • Total Diagnosed Cases of Diabetic Retinopathy
  • Diagnosed Prevalent Cases according to segmentation: Gender-specific cases of Diabetic Retinopathy
  • Diagnosed Prevalent Cases according to segmentation: Age-specific cases of Diabetic Retinopathy 
  • Diagnosed Prevalent Cases according to segmentation: Severity-specific cases of Diabetic Retinopathy 

KOL- Views

We interview KOLs, and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Diabetic Retinopathy?
  • What are the key findings pertaining to the Diabetic Retinopathy epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2021–2030)?
  • What would be the total number of patients of Diabetic Retinopathy across the 7MM during the forecast period (2021–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021–2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2021–2030)?
  • What are the disease risk, burden, and unmet needs of the Diabetic Retinopathy?
  • What are the currently available treatments of Diabetic Retinopathy?

Reasons to buy

The Diabetic Retinopathy epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Diabetic Retinopathy market
  • Quantify patient populations in the global Diabetic Retinopathy market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Diabetic Retinopathy therapeutics in each of the markets covered
  • Understand the magnitude of Diabetic Retinopathy population by its Diagnosed cases
  • Understand the magnitude of Diabetic Retinopathy population by its Gender-specific cases
  • Understand the magnitude of Diabetic Retinopathy population by its Age-specific cases
  • Understand the magnitude of Diabetic Retinopathy population by its Severity-specific cases
  • The Diabetic Retinopathy epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
  • The Diabetic Retinopathy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Executive summary

3. Organizations

4. Diabetic Retinopathy: Overview at a Glance

4.1. Introduction

4.2. Diabetes Mellitus

4.2.1. Type 1 Diabetes Mellitus

4.2.2. Type 2 Diabetes Mellitus

4.3. Pathophysiology

4.4. Clinical Presentation

4.5. Diabetic Retinopathy Symptoms

4.6. Diabetic Retinopathy Risk Factors

4.7. Diabetic Retinopathy Classification

4.8. Diagnosis of Diabetic Retinopathy

5. Epidemiology and Patient Population

5.1. Key Findings

5.2. Assumptions and Rationale

5.3. Total cases of Diabetic Retinopathy in the 7MM

5.4. United States

5.4.1. Total Diagnosed cases of Diabetic Retinopathy in the United States

5.4.2. Gender-specific cases of Diabetic Retinopathy in the United States

5.4.3. Age-specific cases of Diabetic Retinopathy in the United States

5.4.4. Severity-specific cases of Diabetic Retinopathy in the United States

5.5. EU5 Countries

5.5.1. Germany

5.5.1.1. Total Diagnosed cases of Diabetic Retinopathy in Germany

5.5.1.2. Gender-specific cases of Diabetic Retinopathy in Germany

5.5.1.3. Age-specific cases of Diabetic Retinopathy in Germany

5.5.1.4. Severity-specific cases of Diabetic Retinopathy in Germany

5.5.2. France

5.5.2.1. Total Diagnosed cases of Diabetic Retinopathy in France

5.5.2.2. Gender-specific cases of Diabetic Retinopathy in France

5.5.2.3. Age-specific cases of Diabetic Retinopathy in France

5.5.2.4. Severity-specific cases of Diabetic Retinopathy in France

5.5.3. Italy

5.5.3.1. Total Diagnosed cases of Diabetic Retinopathy in Italy

5.5.3.2. Gender-specific cases of Diabetic Retinopathy in Italy

5.5.3.3. Age-specific cases of Diabetic Retinopathy in Italy

5.5.3.4. Severity-specific cases of Diabetic Retinopathy in Italy

5.5.4. Spain

5.5.4.1. Total Diagnosed cases of Diabetic Retinopathy in Spain

5.5.4.2. Gender-specific cases of Diabetic Retinopathy in Spain

5.5.4.3. Age-specific cases of Diabetic Retinopathy in Spain

5.5.4.4. Severity-specific cases of Diabetic Retinopathy in Spain

5.5.5. United Kingdom

5.5.5.1. Total Diagnosed cases of Diabetic Retinopathy in the United Kingdom

5.5.5.2. Gender-specific cases of Diabetic Retinopathy in the United Kingdom

5.5.5.3. Age-specific cases of Diabetic Retinopathy in the United Kingdom

5.5.5.4. Severity-specific cases of Diabetic Retinopathy in the United Kingdom

5.6. Japan

5.6.1. Total Diagnosed cases of Diabetic Retinopathy in Japan

5.6.2. Gender-specific cases of Diabetic Retinopathy in Japan

5.6.3. Age-specific cases of Diabetic Retinopathy in Japan

5.6.4. Severity-specific cases of Diabetic Retinopathy in Japan

6. Appendix

6.1. Bibliography

6.2. Report Methodology

7. DelveInsight Capabilities

8. Disclaimer

9. About DelveInsight

List of Table

Table 1: Summary of Diabetic Retinopathy (DR), Market, Epidemiology, and Key Events (2018–2030)

Table 2: Risk Factors

Table 3: Genetic polymorphisms and diabetic retinopathy

Table 4: Total cases of Diabetic Retinopathy in the 7MM (2018–2030)

Table 5: Total Diagnosed cases of Diabetic Retinopathy in the United States (2018–2030)

Table 6: Gender-specific cases of Diabetic Retinopathy in the US (2018–2030)

Table 7: Age-specific cases of Diabetic Retinopathy in the US (2018–2030)

Table 8: Severity-specific cases of Diabetic Retinopathy in the US (2018–2030)

Table 9: Total Diagnosed cases of Diabetic Retinopathy in Germany (2018–2030)

Table 10: Gender-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Table 11: Age-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Table 12: Severity-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Table 13:  Total Diagnosed cases of Diabetic Retinopathy in France (2018–2030)

Table 14: Gender-specific cases of Diabetic Retinopathy in France (2018–2030)

Table 15: Age-specific cases of Diabetic Retinopathy in France (2018–2030)

Table 16: Severity-specific cases of Diabetic Retinopathy in France (2018–2030)

Table 17: Total Diagnosed cases of Diabetic Retinopathy in Italy (2018–2030)

Table 18: Gender-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Table 19: Age-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Table 20: Severity-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Table 21: Total Diagnosed cases of Diabetic Retinopathy in Spain (2018–2030)

Table 22: Gender-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Table 23: Age-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Table 24: Severity-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Table 25: Total Diagnosed cases of Diabetic Retinopathy in the United Kingdom (2018–2030)

Table 26: Gender-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Table 27: Age-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Table 28: Severity-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Table 29: Total Diagnosed cases of Diabetic Retinopathy in Japan (2018–2030)

Table 30: Gender-specific cases of Diabetic Retinopathy in Japan (2018–2030)

Table 31: Age-specific cases of Diabetic Retinopathy in Japan (2018–2030)

Table 32: Severity-specific cases of Diabetic Retinopathy in Japan (2018–2030)

List of Figures

Figure 1: Pathways involved in Diabetic Retinopathy

Figure 2: Risk factors for Diabetic retinopathy

Figure 3: Total cases of Diabetic Retinopathy in the 7MM (2018–2030)

Figure 4: Total Diagnosed cases of Diabetic Retinopathy in the United States (2018–2030)

Figure 5: Gender-specific cases of Diabetic Retinopathy in the US (2018–2030)

Figure 6: Age-specific cases of Diabetic Retinopathy in the US (2018–2030)

Figure 7: Severity-specific cases of Diabetic Retinopathy in the US (2018–2030)

Figure 8: Total Diagnosed cases of Diabetic Retinopathy in Germany (2018–2030)

Figure 9: Gender-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Figure 10: Age-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Figure 11: Severity-specific cases of Diabetic Retinopathy in Germany (2018–2030)

Figure 12: Total Diagnosed cases of Diabetic Retinopathy in France (2018–2030)

Figure 13: Gender-specific cases of Diabetic Retinopathy in France (2018–2030)

Figure 14: Age-specific cases of Diabetic Retinopathy in France (2018–2030)

Figure 15: Severity-specific cases of Diabetic Retinopathy in France (2018–2030)

Figure 16: Total Diagnosed cases of Diabetic Retinopathy in Italy (2018–2030)

Figure 17: Gender-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Figure 18: Age-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Figure 19: Severity-specific cases of Diabetic Retinopathy in Italy (2018–2030)

Figure 20: Total Diagnosed cases of Diabetic Retinopathy in Spain (2018–2030)

Figure 21: Gender-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Figure 22: Age-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Figure 23: Severity-specific cases of Diabetic Retinopathy in Spain (2018–2030)

Figure 24: Total Diagnosed cases of Diabetic Retinopathy in the United Kingdom (2018–2030)

Figure 25: Gender-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Figure 26: Age-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Figure 27: Severity-specific cases of Diabetic Retinopathy in the UK (2018–2030)

Figure 28: Total Diagnosed cases of Diabetic Retinopathy in Japan (2018–2030)

Figure 29: Gender-specific cases of Diabetic Retinopathy in Japan (2018–2030)

Figure 30: Age-specific cases of Diabetic Retinopathy in Japan (2018–2030)

Figure 31: Severity-specific cases of Diabetic Retinopathy in Japan (2018–2030)

  • Tags:
  • Diabetic Retinopathy Epidemiology
  • Diabetic Retinopathy
  • Diabetic Retinopathy Pipeline
  • Diabetic Retinopathy Companies
  • Diabetic Retinopathy prevalent pop...
  • Diabetic Retinopathy incident popu...
  • Diabetic Retinopathy patients diag...
  • Diabetic Retinopathy treatment alg...

Forward to Friend

Need A Quote